UMB Bank’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.3K | Buy |
953
+156
| +20% | +$2.67K | ﹤0.01% | 1449 |
|
2025
Q1 | $50.9K | Buy |
797
+276
| +53% | +$17.6K | ﹤0.01% | 1045 |
|
2024
Q4 | $63.3K | Buy |
521
+138
| +36% | +$16.8K | ﹤0.01% | 821 |
|
2024
Q3 | $47.8K | Buy |
383
+197
| +106% | +$24.6K | ﹤0.01% | 888 |
|
2024
Q2 | $29.4K | Buy |
186
+47
| +34% | +$7.43K | ﹤0.01% | 956 |
|
2024
Q1 | $18K | Hold |
139
| – | – | ﹤0.01% | 1117 |
|
2023
Q4 | $13.4K | Sell |
139
-37
| -21% | -$3.57K | ﹤0.01% | 1193 |
|
2023
Q3 | $21.3K | Hold |
176
| – | – | ﹤0.01% | 1061 |
|
2023
Q2 | $20.2K | Sell |
176
-151
| -46% | -$17.3K | ﹤0.01% | 1094 |
|
2023
Q1 | $45.1K | Hold |
327
| – | – | ﹤0.01% | 861 |
|
2022
Q4 | $42K | Hold |
327
| – | – | ﹤0.01% | 893 |
|
2022
Q3 | $36K | Sell |
327
-50
| -13% | -$5.51K | ﹤0.01% | 951 |
|
2022
Q2 | $29K | Sell |
377
-379
| -50% | -$29.2K | ﹤0.01% | 1055 |
|
2022
Q1 | $59K | Hold |
756
| – | – | ﹤0.01% | 924 |
|
2021
Q4 | $69K | Buy |
+756
| New | +$69K | ﹤0.01% | 899 |
|